[GLP-1: a new therapeutic principle for the treatment of type 2 diabetes mellitus].
Menge
Björn A
BA
Medizinische Klinik I, St. Josef-Hospital, Universitätsklinikum der Ruhr-Universität Bochum, Bochum. bjoern.menge@rub.de
Meier
Juris J
JJ
Schmidt
Wolfgang E
WE
D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4; D054873:Dipeptidyl-Peptidase IV Inhibitors; D017277:Drug Approval; D004359:Drug Therapy, Combination; D052216:Glucagon-Like Peptide 1 / Q000819:agonists* / Q000502:physiology; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D054795:Incretins / Q000502:physiology; D007328:Insulin / Q000097:blood; D008297:Male; D008687:Metformin / Q000008:administration & dosage*; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage*; D012307:Risk Factors; D012528:Satiety Response / Q000187:drug effects / Q000502:physiology; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000008:administration & dosage*; D015431:Weight Loss / Q000187:drug effects / Q000502:physiology
D001786:Blood Glucose; D018819:Dipeptidyl Peptidase 4; D054873:Dipeptidyl-Peptidase IV Inhibitors; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D054795:Incretins; D007328:Insulin; D008687:Metformin; D011719:Pyrazines; D000068900:Sitagliptin Phosphate; D014230:Triazoles; C517652:hemoglobin A1c protein, human; C042807:DPP4 protein, human